Photothermal-Controlled Generation of Alkyl Radical from Organic Nanoparticles for Tumor Treatment
Overview
Biotechnology
Authors
Affiliations
The therapeutic properties of light are well known for photodynamic or photothermal therapy, which could cause irreversible photodamage to tumor tissues. Although photodynamic therapy (PDT) has been proved in the clinic, the efficacy is not satisfactory because of complicated tumor microenvironments. For example, the hypoxia in solid tumor has a negative effect on the generation of singlet oxygen. To address the hypoxia issues in PDT, leveraging alkyl radical is an available option due to the oxygen-independent feature. In this work, a new kind of organic nanoparticles (tripolyphosphate (TPP)-NN NPs) from porphyrin and radical initiator is developed. Under near-infrared light irradiation, TPP-NN NPs will split and release alkyl radical, which could induce obvious cytotoxicity both in normal and hypoxia environment. The photothermal-controlled generation of alkyl radical could significantly inhibit the growth of cervical cancer and show ignorable systemic toxicity. This activatable radical therapy opens up new possibilities for the application of PDT in hypoxia condition.
Wu X, Zhou Z, Li K, Liu S Adv Sci (Weinh). 2024; 11(16):e2308632.
PMID: 38380505 PMC: 11040387. DOI: 10.1002/advs.202308632.
Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy.
Ning S, Liu Z, Chen M, Zhu D, Huang Q Nanoscale Adv. 2022; 4(18):3950-3956.
PMID: 36133353 PMC: 9470029. DOI: 10.1039/d2na00395c.
Research Progress of Conjugated Nanomedicine for Cancer Treatment.
Zhao B, Chen S, Hong Y, Jia L, Zhou Y, He X Pharmaceutics. 2022; 14(7).
PMID: 35890416 PMC: 9315807. DOI: 10.3390/pharmaceutics14071522.
Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy.
Hong L, Li J, Luo Y, Guo T, Zhang C, Ou S Biomolecules. 2022; 12(1).
PMID: 35053229 PMC: 8774200. DOI: 10.3390/biom12010081.
Photoactivatable nanogenerators of reactive species for cancer therapy.
Zheng X, Jin Y, Liu X, Liu T, Wang W, Yu H Bioact Mater. 2021; 6(12):4301-4318.
PMID: 33997507 PMC: 8105601. DOI: 10.1016/j.bioactmat.2021.04.030.